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Abstract
Background: MicroRNAs (miRNAs) are a class of small non-coding RNAs that have recently emerged as important regulators
of gene expression. They negatively regulate gene expression post-transcriptionally by translational repression and target
mRNA degradation. miRNAs have been shown to play crucial roles in muscle development and in regulation of muscle cell
proliferation and differentiation.
Methodology/Principal Findings: By comparing miRNA expression profiling of proliferating myoblasts versus differentiated
myotubes, a number of modulated miRNAs, not previously implicated in regulation of myogenic differentiation, were
identified. Among these, miR-221 and miR-222 were strongly down-regulated upon differentiation of both primary and
established myogenic cells. Conversely, miR-221 and miR-222 expression was restored in post-mitotic, terminally
differentiated myotubes subjected to Src tyrosine kinase activation. By the use of specific inhibitors we provide evidence
that expression of miR-221 and miR-222 is under the control of the Ras-MAPK pathway. Both in myoblasts and in myotubes,
levels of the cell cycle inhibitor p27 inversely correlated with miR-221 and miR-222 expression, and indeed we show that
p27 mRNA is a direct target of these miRNAs in myogenic cells. Ectopic expression of miR-221 and miR-222 in myoblasts
undergoing differentiation induced a delay in withdrawal from the cell cycle and in myogenin expression, followed by
inhibition of sarcomeric protein accumulation. When miR-221 and miR-222 were expressed in myotubes undergoing
maturation, a profound alteration of myofibrillar organization was observed.
Conclusions/Significance: miR-221 and miR-222 have been found to be modulated during myogenesis and to play a role
both in the progression from myoblasts to myocytes and in the achievement of the fully differentiated phenotype.
Identification of miRNAs modulating muscle gene expression is crucial for the understanding of the circuits controlling
skeletal muscle differentiation and maintenance.
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Introduction
Skeletal myogenesis requires the occurrence of specific coordi-
nated events, including exit from the cell cycle, transcription of
muscle-specific proteins, fusion into polynucleated fibers and
assembly of the contractile apparatus. Such complex processes are
regulated at multiple levels. Determination and differentiation
pathways are under the control of the MyoD family of myogenic
regulatory factors (MRFs) that cooperate with members of the
myocyte enhancer factor-2 family of transcription factors to
synergistically activate muscle-specific gene transcription by
recruiting chromatin remodeling proteins [1,2]. A fundamental
role in establishing and maintaining the post-mitotic state of
differentiated cells is played by cyclin-dependent kinase inhibitors
(CDKIs) such as p21, p27 and p57 that function by coupling cell
cycle arrest and cell differentiation [3]. Moreover, there is
evidence for the existence of a functional cross-talk between
CDKIs and MRFs [4,5], critical for induction of myogenesis.
Recent studies have identified the post-transcriptional control of
gene expression as a crucial level of regulation of myogenesis.
Among the critical mediators of such control, an important role is
played by miRNAs, small non coding RNAs that specifically bind
the 39untranslated regions (39UTRs) of mRNAs and control their
stability and translational efficiency [6,7]. Several miRNAs have
been identified, some of which, miR-1, miR-133a and miR-206,
are expressed specifically in muscle tissue [8,9]. The binding of
MRFs to the presumptive promoters of muscle-restricted miRNAs,
together with the over-expression and knock-down of these
PLoS ONE | www.plosone.org 1 October 2009 | Volume 4 | Issue 10 | e7607miRNAs in muscle tissues and in myogenic cell lines [10,11], have
provided experimental support for their role in muscle differen-
tiation. Interestingly, miR-1 and miR-206 promote myogenesis by
targeting transcriptional repressors of muscle gene expression,
whereas miR-133 inhibits myogenesis by enhancing myoblast
proliferation [12,13]. Little is known on how extracellular signals
impinge on the regulation of miRNAs involved in myogenic
differentiation.
Expression of oncogenes or exogenous growth factors has been
shown to interfere with myogenic differentiation by modulating
various extracellular-signal activated pathways involved in regu-
lation of skeletal muscle differentiation [14]. Activation of the p38
mitogen activated protein kinase (MAPK) pathway promotes
muscle differentiation, while its inhibition prevents expression of
muscle-specific genes and fusion of myocytes [15]. Oncogenic
activation of the Ras-MAPK pathway, instead, inhibits muscle
differentiation in most cell models studied, whereas inhibition of
endogenous MEK usually favors differentiation [16,17]. Trans-
formation of quail embryo myoblasts with temperature-sensitive
mutants of the v-src oncogene (QMb-ts) allows cells to proliferate
in low mitogen medium at the permissive temperature for the Src
kinase and to fully differentiate into myotubes that assemble highly
ordered sarcomeric structures at the restrictive temperature [18].
The block of differentiation of quail myoblasts transformed by ts-
Src is mainly due to the constitutive activation of Ras-MAPK and
inhibition of p38 MAPK pathways [16]. A unique property of this
cell context is that the ts kinase can be reactivated in terminally
differentiated myotubes leading to marked changes in muscle-
specific mRNA stability and prominent defects in the assembly of
contractile proteins [18,19].
In this study, we made use of the QMb-ts myoblast model,
which faithfully reproduces myogenesis in vitro, in order to identify
novel miRNAs that are specifically modulated in both differen-
tiation and maturation of skeletal muscle cells. Two of them, miR-
221 and miR-222, are down-regulated upon differentiation of
avian and mammalian myoblasts and are under the control of the
Ras-MAPK signaling pathway. We show that p27 is a target of
miR-221 and miR-222 in myoblasts and in myotubes subjected to
Src activation and that alterations of their expression lead to
defects in the transition from myoblasts to myocytes and in the
assembly of sarcomeres in myotubes.
Results
microRNA expression profiling upon myogenic
differentiation
Polyclonal populations of QMb-ts cells can be kept proliferating
both in growing (GM) and differentiation medium (DM) at the
permissive temperature for the v-Src kinase (35uC) and can
synchronously differentiate into multinucleate myotubes exhibiting
a high degree of fusion (over 90%) and structural maturation when
shifted to the restrictive temperature (41uC). In addition, the ts
kinase can be reactivated in myotubes by a simple temperature
shift (from 41uCt o3 5 uC) resulting in profound alterations of the
differentiated phenotype [18]. To search for miRNAs specifically
modulated during the progression from myoblasts to myotubes
and in myotubes subjected to Src-induced perturbation, a miRNA
expression profile was determined by quantitative real-time PCR
in proliferating myoblasts maintained at 35uC in DM, in myoblasts
allowed to differentiate for 48 hours at 41uC in DM, and
myotubes differentiated at 41uC for 30 hours and then shifted to
35uC for 18 hours (Table S1). Novel miRNAs, not previously
described as linked to myogenic differentiation, were identified
and, among them, we chose all miRNAs showing a degree of
modulation between myoblasts and myotubes bigger than eight-
fold, and a selected group of microRNAs modulated to a lesser
extent (Fig. 1). Expression of miR-16, previously found to be
unaffected by muscle differentiation, was used to normalize
different samples and microRNA modulation was expressed as
fold increase or decrease in myotubes, compared to myoblasts.
Two miRNAs, miR-135a and miR-367, were strongly up-
regulated in differentiated myotubes to an extent comparable to
that measured for miR-1 and miR-133a, previously shown to be
specifically up-regulated in differentiated murine muscle cells [12].
Upon Src activation in myotubes, these miRNAs, with the
exception of miR-367, were moderately down-regulated. On the
contrary, miR-221, miR-222 and miR-29b were down-modulated
in differentiated myotubes. Other members of the miR-29-family,
namely miR29a and miR29c, although occupying chromosomal
positions adjacent to miR-29b, were down-modulated to a lesser
extent. Consistent with our results, a slight down-modulation of
miR-29 family members has been previously reported upon
differentiation of C2C12 mouse myoblasts [12]. In contrast, these
miRNAs have been found up-modulated upon differentiation of
C2C12 and human myoblasts by another group [20], possibly due
to different culture conditions. miR-223 was also included among
the modulated miRNAs shown in Fig. 1 due to its previously
recognized role in granulocytic differentiation [21]. Expression of
miR-221, miR-222 and miR-29b, strongly reduced in myotubes,
was induced upon shift to 35u to levels comparable to myoblasts,
highlighting a possible role of these miRNAs in both myoblasts
and myotubes subjected to Src-induced alteration.
Among the modulated miRNAs we pursued the study of miR-
221 and miR-222 (miR-221/222), previously implicated in tumor
cell proliferation [22–24], since little is known about their possible
involvement in myogenesis. Northern blot analysis of miR-221/
222 expression in QMb-ts cells confirmed that these miRNAs are
highly expressed in proliferating myoblasts, down-regulated in
differentiated myotubes and that their regulation is opposite to
that of miR-133 (Fig. 2). In addition, their re-induction in quail
myotubes following Src activation shows that they can be
modulated independently of proliferation.
In order to establish their possible role in myogenic differen-
tiation, modulation of miR-221/222 was analyzed in other
myogenic cell contexts, such as primary quail myoblasts (QMb),
primary mouse satellite cells (MSC) and two well characterized
rodent cell lines: mouse C2C12 and rat L6C5 myoblasts. RNAs
extracted from these cell types both in GM and DM at different
time points were analyzed for the expression of miR-221/222 by
quantitative PCR. As shown in Table 1, miR-221/222 were
down-modulated upon terminal differentiation in all myogenic
cells analyzed, whether primary myoblasts or established cell lines,
albeit to different extents and with different kinetics, indeed
suggesting their involvement in regulation of differentiation. While
the modulation of miR-221/222 in avian myoblasts was
pronounced, an average two-fold modulation was observed in all
mammalian myoblasts analyzed, in keeping with previous reports
in other cell contexts [25] where a similar modulation was shown
to be functionally relevant. miR-1 was also analyzed as control.
Expression of miR-221/222 inversely correlates with p27
accumulation and is under control of the Ras-MAPK
pathway
Being p27 CDKI a direct target of miR-221 and miR-222 in
human cancer cells [22–24], we investigated whether there was a
correlation between p27 and miR-221 and miR-222 expression in
myogenic cells. Therefore, QMb-ts myoblasts induced to differen-
tiate at 41uC or myotubes subjected to Src activation were analyzed
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mRNA, and for the expression of miR-221/222. Upon shift to
differentiation-permissive conditions, both p27 mRNA and protein
expression were induced, whereas the expression of miR-221/222
was correspondingly reduced (Fig. 3A). In contrast, when Src was
activated in myotubes, p27 protein levels were reduced up to 5 fold
while p27 mRNA levels were barely affected (Fig. 3B), suggesting
that down-regulationof p27proteininvolves translational inhibition
mechanisms, possibly dependent on the corresponding increased
accumulation of miR-221/222. Note that expression of p27 is
probably a combination of transcriptional and post-transcriptional
mechanisms, in keeping with previous reports showing that
inhibition of p27 accumulation in Src-transformed fibroblasts is
due to reduced transcription and to protein destabilization [26,27].
We have recently reported that activation of the Ras-MAPK
pathway by Src in quail myogenic cells is largely responsible for
inhibition of differentiation both in myoblasts and in post-mitotic
myocytes [16]. In this context, we investigated whether this
pathway was also involved in the regulation of miR-221/222
expression. Therefore, QMb-ts were treated at 35uC with the
MEK inhibitor U0126, or infected with adenoviruses expressing
RasN17, a dominant negative Ras mutant, or GFP as control.
After 2 days, myoblasts were analyzed for expression of miR-221/
222 and miR-1 and for the accumulation of p27 and muscle-
specific proteins. Inhibition of the Ras-MAPK pathway by
RasN17 or U0126 efficiently inhibited accumulation of miR-
221/222 and induced expression of miR-1 (Fig. 4A) concomitantly
to that of p27 protein and sarcomeric myosin and a-actinin
(Fig. 4B). Note that the levels of miR-221/222 following block of
Ras-MAPK pathway are comparable to those observed in
myotubes at 41uC, further supporting the central role played by
the Ras-MAPK pathway in controlling expression of miR-221/
222 downstream of Src. In order to verify whether this pathway
was involved in miR-221/222 regulation independently of
proliferation, QMb-ts myotubes were subjected to Src activation
in the presence of U0126 and analyzed for the expression of miR-
221/222 and miR-1. As shown in Fig. 4C, inhibition of the Ras-
MAPK pathway in post-mitotic myotubes resulted in expression
levels of miR-221/222 comparable to those of myotubes,
counteracting the increase observed following Src activation.
Interestingly, in contrast to miR-221/222, expression of miR-1
was relatively insensitive to both Src activity (see also Fig. 1) and
inhibition of the Ras-MAPK pathway in myotubes (Fig. 4C).
Concerning p27, the inhibition of the Ras-MAPK pathway
reduced only in part the decrease caused by Src activation in
myotubes, (Fig. 4C), probably due to protein destabilization
Figure 1. Profiling of modulated miRNAs in QMb-ts. miRNA expression was measured in QMb-ts, cultivated either at 35uCo r4 1 uC for 48 hours
and in QMb-ts maintained at 41uC for 30 hours and shifted to 35uC for additional 18 hours. Values in table were normalized according to median
values and expressed as a function of values at 35uC DM using the comparative Ct method. Standard error (s.e.) and statistical significance (p, n=6)
are shown. P values in red are not statistically significant. Heat map representing miRNA modulation is expressed in a linear scale with a maximum
value of 16 fold to highlight differences within this range. Green and red luts indicate down- and up-regulation, respectively.
doi:10.1371/journal.pone.0007607.g001
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U0126 and of Src activation was monitored by measuring the
levels of phosphorylated p42/44 MAPK since no changes in
muscle-specific protein accumulation are detectable in myotubes
24 hours after Src activation [18]. These results clearly indicate
that the Ras-MAPK pathway regulates expression of miR-221/
222 independently of proliferation.
p27 is a target of miR-221 and miR-222 in avian and
mammalian myoblasts
Since the inverse regulation of expression of p27 protein and
miR-221/222 was compatible with p27 mRNA being a target of
these miRNAs also in myoblasts, we addressed this point by over-
expressing or inhibiting miR-221/222 in a variety of avian and
mammalian cell contexts. Therefore, QMb-ts, QMb, C2C12,
L6C5 and MSC myoblasts were transfected with miR-221, miR-
222 or control (siGFP) duplex RNAs, induced to differentiate in
DM for two days and analyzed for the expression of p27 protein.
Accumulation of p27 was strongly inhibited by both miRNAs
upon differentiation of normal and Src-transformed quail
myoblasts (Fig. 5A) and significantly reduced in mammalian
myocytes (Fig. 5B). Accumulation of p27 mRNA in the same cells
was reduced 2–3 fold (not shown), in keeping with the recent
finding that miR-dependent translational repression is often
accompanied by mRNA destabilization [28,29]. We then analyzed
the consequence of inhibiting endogenous miR-221/222 on
accumulation of p27. In order to best evaluate the effects of
miR-221/222 inhibition, antisense miRNA inhibitors were
transfected in QMb-ts myotubes shifted to 35uC, and in
proliferating C2C12 myoblasts, cell contexts where the levels of
p27 protein, but not of p27 mRNA, are low (see Fig. 3 and [4]). In
both cell types, inhibition of miR-221/222 resulted in a partial
recovery of p27 accumulation (Fig. 5C,D), suggesting that p27
mRNA is regulated by these miRNAs in myogenic cells.
To definitively validate quail p27 mRNA as a target of miR-
221/222, the full-length p27-39UTR of quail mRNA and a shorter
portion containing two identified target sites for these miRNAs
were cloned downstream to the luciferase coding region of the
pGL3 reporter vector. Control pGL3 reporter vector or pGL3
containing the short portion (s-UTR) or the full length (UTR) p27-
39UTR were transfected in QMb-ts myoblasts and luciferase
activity was measured both in myoblasts and in myotubes (Fig. 6A).
A significant decrease in luciferase activity of both p27-39UTR
constructs was detected in myoblasts compared to myotubes,
suggesting that endogenous miR-221/222 are competent for
inhibition of p27 mRNA translation in these cells. Co-transfection
of myoblasts with the p27-39UTR reporters along with miR-221/
222 antisense inhibitors (Fig. 6B) or with miR-221/222 duplexes
(Fig. 6C) further demonstrated that quail p27-39UTR mRNA is a
direct target of miR-221/222 and that inhibition of luciferase
Figure 2. Expression of miR-221, miR-222 and muscle specific
miR-133 in QMb-ts myoblasts. Northern blot analysis showing
expression of miR-221 and miR-222, compared to muscle-specific miR-
133, in QMb-ts myoblasts at 35uC, myotubes at 41uC and myotubes
shifted back to 35uC. Numbers represent the quantity of each miR
expressed as fold decrease/increase relative to that measured in
proliferating myoblasts (35u), taken as 1.0. U6 snRNA was used for
normalization.
doi:10.1371/journal.pone.0007607.g002
Table 1. Modulation of miR-221, miR-222 and miR-1 expression upon myogenic differentiation.
miR-221 miR-222 miR-1
fold decrease 6s.e. p fold decrease 6s.e. p fold increase 6s.e. p
QMb-ts 8.0 1.2 0.001 10.1 1.7 0.001 37.1 6.1 0.001
QMb 4.8 1.5 0.001 6.2 1.9 0.001 52.0 18.7 0.01
C2C12 2d 2.0 1.4 0.04 2.5 0.7 0.001 245.8 108.2 0.04
C2C12 4d 1.5 0.4 0.06 2.0 0.5 0.001 179.7 64.1 0.05
L6C5 2d 1.5 0.2 0.009 1.5 0.3 0.009 30.3 28.1 0.13
L6C5 4d 2.0 0.5 0.001 2.2 0.3 0.001 242.2 46.3 0.004
MSC 1d 1.9 0.2 0.001 1.9 0.1 0.001 9.2 5.4 0.10
MSC 2d 1.1 0.3 0.29 1.6 0.4 0.04 25.9 9.4 0.02
RNAs extracted from QMb-ts and QMb induced to differentiate for 2 days, C2C12 mouse myoblasts and L6C5 rat myoblasts induced to differentiate for 2 (2d) and 4 (4d)
days, and MSC induced to differentiate for 1 (1d) and 2 (2d) days were analyzed for the expression of miR-221, miR-222 and miR-1 by real-time RT-PCR. Fold decrease of
miR-221 and miR-222 and fold increase of miR-1 expression in myotubes is shown for each cell type relative to levels detected in proliferating myoblasts. Standard error
(s.e.) and statistical significance (p, n$3; for QMb and MSC, n=3; for L6C5, n=4; for QMb-ts, n=6; for C2C12 n=6) are shown. Not significant p values are underlined.
doi:10.1371/journal.pone.0007607.t001
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specific antisense inhibitors. A pGL3 reporter containing the
human p27-39UTR [24] was also co-transfected in myoblasts with
miR-221/222 duplexes for comparison and found to be regulated
also in avian cells (Fig. 6C). In conclusion, we show that in
myogenic cells miR-221 and miR-222 play a critical role in finely
regulating p27 protein dosage.
Ectopic expression of miR-221/222 leads to inhibition of
muscle-specific gene expression in myocytes and alters
maturation of myotubes
In order to investigate the functional role of miR-221 and miR-
222 in progression to terminal differentiation, miR-221/222 were
ectopically expressed in proliferating myoblasts and the rate of exit
from the cell cycle and accumulation of the early myogenic
transcription factor myogenin were measured. QMb-ts myoblasts
transfected with miR-221, miR-222 or both and control duplex
RNAs at 35uC in GM, were induced to differentiate at 41uCi n
DM for various lengths of time. At each time point, cells were
labeled with BrdU for 2 hours, fixed and processed for
immunofluorescence with antibodies to BrdU and myogenin and
scored for positive cells. As shown in Fig. 7A and 7B, ectopic
expression of miR-221/222 induced a slight, but consistent delay
in the exit from the cell cycle up to 12 hours after induction of
differentiation and a decrease in the accumulation of myogenin,
most evident between 8 and 24 hours.
In order to establish whether the delay in myogenin
accumulation influenced the accumulation of sarcomeric proteins,
QMb-ts myoblasts overexpressing miR-221/222 were allowed to
differentiate for two days and cell extracts were analyzed by
Western blot. As shown in Fig. 8A, a significant reduction in the
accumulation of muscle-specific myosin heavy chain and a-actinin
was observed concomitant to p27 protein reduction. This reduced
accumulation of myofibrillar proteins was accompanied by an
altered cellular morphology, characterized by widening and
flattening of myotubes and loss of alignment and clustering of
Figure 3. Kinetics of p27, miR-221 and miR-222 accumulation in QMb-ts upon induction of differentiation at 41uC and shift down of
myotubes to 35uC. (A) QMb-ts myoblasts allowed to differentiate in DM upon temperature shift from 35uCt o4 1 uC and (B) myotubes differentiated
in DM for 40 hours at 41uC (41-T0) subjected to Src activation at 35uC were analysed at different time points for expression of p27 protein by Western
blot (upper panels) and of p27 mRNA, miR-221 and miR-222 by real time RT-PCR. In B, 41-T24 represents control myotubes kept at 41uC for additional
24 hours. Accumulation levels of p27 protein and mRNA, miR-221 and miR-222, expressed relative to levels detected at 41uC, taken as 1.0, are shown
in the histograms, normalized for p38 protein, GAPDH mRNA and miR-16 respectively. Error bars represent standard error (n=3).
doi:10.1371/journal.pone.0007607.g003
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PLoS ONE | www.plosone.org 5 October 2009 | Volume 4 | Issue 10 | e7607Figure 4. Expression of miR-221 and miR-222 is under the control of the Ras-MAPK pathway. (A, B) Proliferating QMb-ts were treated in
DM at 35uC for two days with DMSO (vehicle) or with the MEK inhibitor U0126 (U0126), or infected with adenoviruses expressing GFP (ad-GFP) or a
dominant interfering Ras mutant (ad-RasN17). QMb-ts in DM at 41uC are shown for comparison. After 2 days, cells were analysed for (A) expression of
miR-221, miR-222 and miR-1 by real time RT-PCR and (B) accumulation of p27 and muscle-specific proteins by western blot. (C) QMb-ts myotubes
kept at 41u for 30 hours (41u (T0)) were treated with DMSO (vehicle) or U0126 (U0126) and shifted to 35u for 20 hours. Fold modulation of miRNA
expression shown in (A) and (C), normalized for miR-16 expression, is expressed relative to cell extracts at 35uC (A) and myotubes differentiated for
30 hours at 41uC (C), taken as 1.0. Error bars represent standard error and the observed differences are statistically significant (p,0.05; n$3).
doi:10.1371/journal.pone.0007607.g004
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expression of miR-221/222 in post-mitotic myocytes could lead
to alterations in myotube maturation, QMb-ts and MSC myocytes
were transfected with miR221/222 and, three days later, analyzed
for the expression of p27, muscle-specific myosin and cell
morphology. As observed in QMb-ts myoblasts undergoing
differentiation, ectopic expression of miR-221/222 in post-mitotic
myocytes induced a reduction of p27 (Fig. 8B and Fig. 9B) and
myosin accumulation (Fig. 8B and not shown), accompanied, in
MSC, by diminished cell fusion (Fig. 9C), as emphasized by the
high percentage of myotubes with a small number of nuclei,
compared to control (Fig. 8C).
A specific trait of the terminally differentiated muscle phenotype
is the assembly of a highly ordered array of myofibrils. Therefore,
organization of myofibrils was analyzed after transfection of miR-
221/222 in 1-day-old QMb-ts and MSC myocytes undergoing
maturation. As shown in Fig. 9B, QMb-ts myotubes expressing
miR-221/222, recognizable by the reduced levels of p27 protein in
nuclei, displayed misalignment of myofibrils and reduced sarco-
mere assembly, highlighted by the poor cross-striation pattern
evidenced by myosin staining, as compared to controls transfected
with siGFP. A similar phenotype was observed in MSC myotubes
expressing miR-221/222 (Fig. 9D). Note that monoclonal
antibody (mAb) to p27 does not recognize the antigen in MSC
by immunofluorescence. Levels of p27, therefore, were routinely
measured in parallel cultures by western blot analysis, as in Fig. 8B.
Altogether these findings strengthen the notion that the expression
of miR-221 and miR-222 needs to be tightly regulated during
differentiation and suggest the existence of a role of these miRNAs
both in progression of myogenic differentiation and in achieve-
ment of the differentiated phenotype.
Discussion
Beside the well-defined transcriptional level of regulation, the
discovery of miRNAs adds a new layer of post-transcriptional
mechanisms that appear to fine tune protein dosages of key
regulators during muscle differentiation. Importantly, the emerg-
ing crucial role of miRNAs in animal development suggests that
Figure 5. Over-expression and inhibition of miR-221 and miR-222 result in modulation of p27. Western blot analysis of p27 in myotubes
derived from (A) QMb-ts and primary QMb and (B) C2C12, L6C5 and MSC myoblasts transfected with control siGFP (siGFP), miR-221 (221), miR-222
(222) or both (221+222) duplex RNAs and allowed to differentiate for two days. p27 expression in (C) QMb-ts myotubes transfected with antisense
inhibitors to GFP (aGFP), used as control, miR-221 (a221), miR-222 (a222) or both (a221+a222) and shifted to 35uC for 24 hours and in (D) C2C12
myoblasts transfected with the same duplexes in GM and analysed 24 hours. Untransfected (n.t.) myoblasts in DM at 35uC or GM and (n.t.) myotubes
in DM are shown as controls. Numbers represent levels of p27 expressed as fold decrease/increase relative to that measured in controls (siGFP), taken
as 1.0. p38 protein levels were used for normalization.
doi:10.1371/journal.pone.0007607.g005
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recent studies have shown that deregulation of miRNAs is linked
to skeletal and cardiac hypertrophy and muscular dystrophy [30–
32]. By comparing miRNA expression profiling of proliferating
quail embryo myoblasts and terminally differentiated myotubes,
we identified a number of miRNAs strongly modulated upon
differentiation that had not been previously described in other
myogenic cell contexts. Two of them in particular, miR-221 and
miR-222, were down-regulated during differentiation in all
myogenic cells examined. Expression of miR-221 and miR-222
was restored in post-mitotic avian myotubes subjected to activation
of thermolabile Src kinase, a finding that correlates with the
consistently elevated levels of miR-222 expression observed in
human muscle disorders [31] and in muscles of 3- and 18-months-
old mdx dystrophic mice (B. C., L. C. and G. F., unpublished
observations). Together, these findings strongly suggest that miR-
222 plays a role in muscle cell damage. miR-221 and miR-222 are
both up-regulated in several tumor-derived cell lines and in cancer
patients and recent studies suggest that miR-221 and miR-222
promote cell cycle progression of tumor cells [33–35]. Interest-
ingly, we found that expression of miR-221/222 can be induced in
a post-mitotic context, thus in a proliferation-independent fashion.
miR-221/222 have been shown to control protein levels of the
cell-cycle inhibitors p27 and p57 [22–24,36,37]. Here we report
that also in myogenic cells the coordinated expression of miR-221
Figure 6. The 39UTR of quail p27 mRNA is a direct target of
miR-221 and miR-222. Firefly luciferase activity was measured in
QMb-ts after transfection of pGL3 reporter vectors carrying the entire
(UTR) or a portion (s-UTR) of the quail p27-39UTR containing the target
sites for miR-221 and miR-222. (A) pGL3 reporter vectors were
transfected and luciferase activities were measured in myoblasts (35u)
and myotubes (41u) cultivated in DM; (B) pGL3 reporter vectors were
cotransfected with antisense inhibitors to GFP (aGFP) and miR-221 and
miR-222 (a221+a222) in myoblasts at 35uC in DM; (C) pGL3 reporter
vectors were cotransfected with control (GFP) or miR-221 and miR-222
(221+222) duplexes in myoblasts at 35uC. In (C) also a human p27-39UTR
(h-UTR) is shown for comparison. The transfection efficiency was
accounted for by cotransfection with the renilla luciferase reporter pRL.
Activities of UTR, s-UTR and h-UTR were normalized on activity of pGL3
empty vector transfected in parallel plates, and expressed relative to
activity at 35u (A), to activity of control aGFP (B) and control GFP (C),
taken as 1.0. Error bars represent standard error and the observed
differences are all statistically significant (p,0.05; n$3).
doi:10.1371/journal.pone.0007607.g006
Figure 7. Ectopic expression of miR-221 and miR-222 delays
exit from the cell cycle and inhibits myogenin accumulation.
QMb-ts were transfected with control (siGFP) or miR-221 and miR-222
duplexes (miR221+222) in GM and transferred to 41uC in DM 24 hours
later. At different time points after temperature shift cells were pulse-
labeled (for 2 hours) with BrdU, fixed and stained for immunofluores-
cence with antibodies to (A) BrdU and (B) myogenin. The percentage of
positive cells relative to total cells is shown in the histograms. Error bars
represent standard error; (*)=p,0.05; (**)=p,0.01; n$3.
doi:10.1371/journal.pone.0007607.g007
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demonstrate that p27 is a direct target of both miRNAs in
myoblasts. In contrast, no down-modulation of p57 was observed
in myotubes from mouse myoblasts over-expressing miR-221/222;
moreover, the avian p57 mRNA homologue does not appear to
harbor putative target sequences for miR-221 and miR-222 (B. C.,
L. C. and G. F., unpublished observations). Over-expression of
miR-221/222 in myoblasts undergoing differentiation, while
Figure 8. miR-221 and miR-222 reduce muscle-specific protein
accumulation and affect cell fusion. (A) QMb-ts transfected at 35uC
with control siGFP, miR-221 (221), miR-222 (222) and both (221+222)
duplex RNAs were shifted to 41uC in DM and allowed to differentiate for
two days. Cell extracts were analyzed by immunoblotting with
antibodies specific for the indicated proteins. (B, C) MSC myocytes
kept in DM for 24 hours were transfected with control siGFP, miR-221
and miR-222 (221+222), and, after 2 days, were either analyzed by
Western blot with antibodies to the proteins indicated in (B) or
processed for immunofluorescence and scored for degree of cell fusion
(C). Protein accumulation levels expressed as fold decrease/increase
relative to those measured in control siGFP, taken as 1.0, are shown in
(A, B). p38 and vinculin protein levels were used for normalization. (C)
Histogram displaying the size distribution of MSC myotubes, labeled
with antibody to myosin heavy chain and with the fluorescent dye
Hoechst 33258, expressed as function of the number of nuclei per
myotube. Error bars represent standard error.
doi:10.1371/journal.pone.0007607.g008
Figure 9. miR-221 and miR-222 induce alterations of myotube
morphology and of myofibrillar organization. (A) QMb-ts
myoblasts were transfected with control duplexes (siGFP) or a mixture
of miR-221 and miR-222 duplexes (221+222), induced to differentiate in
DM at 41uC and, two days later, subjected to double immunofluores-
cence with actin-staining phalloidin and with antibodies specific for
p27, as indicated. (B) QMb-ts myotubes, differentiated in DM at 41uC for
24 hours, were transfected with control duplexes (siGFP) or a mixture of
miR-221 and miR-222 duplexes (221+222), maintained in DM at 41uC for
further 30 hours and subjected to double immunofluorescence with
antibodies specific for skeletal myosin and p27, as indicated. (C–D) MSC
myocytes, differentiated in DM for 24 hours, were transfected with
control duplexes (siGFP) or a mixture of miR-221 and miR-222 duplexes
(221+222), maintained in DM for additional 2 days and subjected to
immunofluorescence with antibodies specific for skeletal myosin. (A–D)
Nuclei were counterstained with Hoechst dye. Note that in (B) and (D)
high magnification micrographs are shown to allow visualization of
sarcomeres. Scale bars: 40 mm (A, C); 10 mm (B–D).
doi:10.1371/journal.pone.0007607.g009
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exit from the cell cycle, was not sufficient to maintain myoblast
proliferation. Our findings are in keeping with the observation that
in tumor cells reduced expression of p27 is not sufficient to sustain
active cell proliferation in the absence of growth factors [37].
Beyond contributing to modulation of cell proliferation, novel
regulatory functions of miR-221 and miR-222 are described in
progression and achievement of full myogenic differentiation.
Indeed, forced expression of miR-221/222 both in myoblasts
induced to differentiate and in post-mitotic myocytes caused a
diminished accumulation of muscle specific proteins and modifi-
cation of cellular morphology. Moreover, both avian and
mammalian myotubes displayed defects in sarcomere assembly,
a specific trait of the fully differentiated phenotype. Having
established that p27 is a target of miR-221 and miR-222 in
myoblasts and is down-modulated by miR-221/222 unscheduled
expression in post-mitotic myocytes, the question arises of whether
inhibition of p27 expression accounts for the observed defects of
myogenic differentiation. It was previously reported that abroga-
tion of p27 in C2C12 myoblasts reduces fusion and expression of
muscle myosin [4], although overall morphology and assembly of
sarcomeric structures were not analyzed. It is noteworthy that,
beyond control of cell cycle, p27 may regulate several other
functions both in myoblasts and in other cell types, such as
cadherin-mediated cell-cell adhesion [4], tumor progression,
apoptosis and cytoskeletal dynamics [38]. Interestingly, a negative
feedback loop has been described to occur between p27 and
RhoA, a pivotal regulator of the actin cytoskeleton [38], and over-
expression in myotubes of RhoA leads to alterations strikingly
similar to those induced by ectopic expression of miR-221 and
miR-222 (L.C. and G.F., unpublished observations). Therefore, it
is possible that the alterations of morphology and sarcomere
assembly that we observe in myotubes expressing ectopic miR-221
and miR-222 are mediated by down-modulation of cell cycle-
independent functions of p27 and/or by inhibition of other targets.
Being the miRNA world a relatively recent field of investigation,
very little is known about the pathways regulating the expression
and function of these RNAs. It was recently reported that
signalling through the ERK MAPK delayed expression of muscle-
specific miRNAs in C2C12 myoblasts undergoing differentiation
[11]. Here we describe for the first time that in QMb-ts myoblasts
induced to differentiate and in post-mitotic myotubes the
expression of miR-221 and miR-222 is under the positive control
of the Ras-MAPK signalling pathway, independently of prolifer-
ation. This well correlates with the finding that inhibition of the
Ras-MAPK pathway in QMb-ts myoblasts induced the expression
of p27 and muscle-specific proteins and the ability to fuse and
assemble contractile structures [16]. We confirm that the Ras-
MAPK pathway negatively regulates expression of miR-1 in
myoblasts, but we show that this miRNA is relatively insensitive to
this pathway in myotubes subjected to Src activation. Src and the
Ras-MAPK pathway have been implicated in repression of MyoD
and myogenin transcriptional activity in myoblasts [17,39–41]
and, recently, MRFs have been shown to regulate transcription of
muscle-restricted miR-1, miR-133 and miR-206 [10,11], likely by
direct binding to their presumptive promoters [10]. In turn,
muscle-specific miRNAs control accumulation of inhibitors of
muscle gene expression, thereby establishing positive feedback
loops resulting in enhanced differentiation [7]. Therefore, the
modulation of miRNA expression observed in QMb-ts may
represent a mechanism linking cytoplasmic intracellular signaling
initiated by Src through MAPK-pathway with nuclear events
leading to transcriptional inhibition of muscle gene expression
[39]. It is becoming clear that miRNAs are important elements of
the differentiation program of skeletal muscle cells. How the
interactions between upstream regulators of miRNAs and the
targets of miRNA activity lead to muscle differentiation and to its
maintenance will require further investigation.
Materials and Methods
Ethic Statement
All animals were handled in strict accordance with good animal
practice as defined by the D.L 116/1992 of the Ministero della
Salute (Italy), and all animal work was approved by the Ministero
della Salute, Dipartimento Alimenti, Nutrizione e Sanita ` Pubblica
Veterinaria- Ufficio Xu.
Materials and antibodies
Highly purified Triton X-100 and NP-40 were from Roche.
FITC and TRITC-conjugated phalloidin and mAb to vinculin
(VIN-11-5) were from Sigma. mAb to BrdU (BU-1) was from GE
Healthcare. mAbs to p27 and to Ras (cl.18) were from
Transduction Laboratories. mAb to skeletal a-actinin (9A2B8)
and myosin heavy chain (MF20) were obtained from D. Fischman.
Rabbit serum to chicken myogenin was provided by B. Paterson.
A rabbit serum to chicken skeletal muscle myosin was developed in
house [39]. Rabbit polyclonal antibodies to p38 were from Santa
Cruz Biotechnology and to phospho- and total p42/44 MAPK
were from Cell Signaling. FITC- and TRITC-conjugated goat
anti-rabbit and anti-mouse antibodies were from Jackson Im-
munoResearch Laboratories. Horseradish peroxidase-conjugated
goat anti-mouse and anti-rabbit antibodies were from Bio-Rad.
Plasmid construction, RNA duplexes and 29-O-Methyl
RNA oligonucleotides
To construct the p27-39UTR luciferase reporter plasmids (UTR
and s-UTR), the full length and a portion of the 39UTR of quail
p27 mRNA were amplified by RT-PCR from total RNA of quail
myotubes using the following primers obtained from the 39UTR
sequence of chicken p27 mRNA (Genbank Accession Number
NM_204256) and containing the XbaI restriction site:
Forward: 59-TATTCTAACTCCCTAAGGCGGAGGACT-39
Reverse 1: 59-TATTCTAGAACAGGGGACCCACTTAAA-
GG-39
Reverse 2: 59-TATTCTAGAACATACAGGTACACAGGC-
AATG-39
The 39UTR PCR products were sequenced and the nucleotide
sequence deposited in the Genbank database (Genbank Accession
Number FJ378653). The fragments were ligated into the XbaI site
downstream to the firefly luciferase coding sequence of the pGL3-
Promoter vector (Promega).
The following sequences of the miRNA duplexes were designed
according to [42]:
miR-221 sense: 59-AGCUACAUUGUCUGCUGGGUUUC-39
miR-221 antisense: 59-AACCCAGCAGACAAUGUAGUUU-
U-39
miR-222 sense: 59-AGCUACAUCUGGCUACUGGGUCUC-
39
miR-222 antisense: 59-GACCCAGUAGCCAGAUGUAGCU-
UU-39
The miRNA duplexes are siRNA-like miRNA mimics that have
been shown to function on target mRNAs as well as endogenous
miRNAs [43]. A Green Fluorescent protein siRNA duplex
(Eurofins) was used as control (siGFP).
The sequences of the 29-O-Me antisense RNA oligonucleotides
were the following:
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AGCU-39
29-O-Me anti miR-222: 59-GAGACCCAGUAGCCAGAU-
GUAGCU-39
29-O-Me anti GFP: 59-UCUUCGGCAAGCUGACCCUGAA-
GUUACCUU-39
Cell cultures and viral infection
Primary cultures of quail myoblasts (QMb) were prepared as
described previously [19] and maintained proliferating in DMEM
supplemented with 10% FCS, 10% tryptose phosphate broth and
3% quail embryo extract (GM) at 37uC. Polyclonal populations of
quail myoblasts transformed by the temperature-sensitive mutant
of the Rous Sarcoma Virus LA29 (QMb-ts) were established as
described [19] and propagated at 35uC in GM devoid of quail
embryo extract. Differentiation was induced by plating the cells on
collagen-coated dishes in GM and, the following day, by
substituting GM with DMEM supplemented with 2% FCS (DM)
and incubating the cell at 41uC. C2C12 [44] and L6C5 myoblasts
[45] (provided by M. Grossi) were maintained proliferating at
37uC in DMEM supplemented with 15% FCS (GM). Differen-
tiation of C2C12 myoblasts was induced by incubating the cultures
in DMEM with 2% horse serum (DM) and of L6C5 myoblasts by
incubating the cells in DMEM with 1% FCS and 1 mg/ml of
insulin. Primary mouse satellite cells (MSC) [46] (provided by D.
Pajalunga) were grown in Ham’s medium supplemented with 20%
FCS, 3% chicken embryo extract and 2.5 ng/ml bFGF.
Differentiation was induced by incubating the cultures in DMEM
with 10% FCS.
High-titer stocks of recombinant adenoviruses expressing GFP
(provided by M. Crescenzi) or RasN17 (provided by L. Parada)
were used to infect QMb-ts cells. Virus expression was scored by
immunofluorescence and only cultures showing a percentage of
infection over 70% were further processed. For treatment with
MEK inhibitor U0126 (Promega), myoblasts were kept for 2 days
at 35uC in DM containing 12.5 mM U0126 or vehicle (DMSO)
and medium was renewed every day; myotubes differentiated for
30 hours at 41uC were shifted to 35uC in DM containing 12.5 mM
U0126 or vehicle (DMSO) for 20 hours.
miRNA quantification
Total RNA was extracted using TRIzol (Invitrogen). RNA
enriched for small RNAs was obtained using the PureLink miRNA
Isolation Kit (Invitrogen), according to the manufacturer’s
instructions. miRNA levels were analyzed using the TaqMan
Real Time PCR method (1 ng/assay), and quantified with ABI
Prism 7000 SDS (Applied Biosystems). Primers for miRNAs and
the reagents for reverse transcription and PCR reactions were all
obtained from Applied Biosystems. Relative expression was
calculated using the comparative Ct method (2
2DDCt) [47].
Different samples were normalized to miR-16 expression.
Conditions for miRNA profiling were previously described [48].
Briefly, to detect mature miRNA species, reverse transcription and
amplification were performed with specific primers and TaqMan
probes. 250 miRNAs were assayed in a 96-well format and
samples were also normalized to the median Ct value. Heat maps
were generated using Genesis software 1.7.2 version (Graz
University of Technology).
RNA expression analysis
Total RNA (30 mg) and RNA enriched for small RNAs (2 mg)
was separated through a 12% denaturing urea-polyacrilamide gel
and transferred to a GeneScreen Plus nylon membrane. miR-221,
miR-222, miR-133 probes (DNA oligonucleotides complementary
to the microRNA sequences) and U6 probes were end labeled with
50 mCi of [c-
32P]dATP. Membranes were hybridized in 5X SSPE,
10% Dextran Sulphate, 5X Denhartd solution, 1% SDS and 50%
formamide at 37uC for 18 hours and washed in 2X SSPE and
0.2% SDS twice at room temperature and once at 37uC. Bands
were visualized on a PhosphorImager (Molecular Dynamics) and
quantified using ImageQuant 5.1 software (Molecular Dynamics).
For quantitative RT-PCR analysis of p27 mRNA, total RNA was
extracted using the TRIzol reagent and retro-transcribed with the
Reverse Transcription System (Promega) using oligo (dT). Primers
for quail p27 mRNA analysis were: (Forward) 59-AGCAAA-
CACCCAAGAAATCGA-39 and (Reverse) 59-CTCCGCCTTA-
GGGAGTTTACG-39; primers for quail GAPDH mRNA analysis
were: (Forward) 59-GAGGGTAGTGAAGGCTGCTG-39 and
(Reverse) 59-CCACAACACGGTTGCTGTAT-39. Analyses were
carried out using Power SYBR Green PCR master mix (Applied
Biosystems) and ABI Prism 7500. Results were normalized with
respect to GAPDH expression. Relative expression was calculated
using the comparative Ct method (2
2DDCt) [47].
Transient transfections and luciferase assays
QMb, QMb-ts, C2C12 and L6C5 myoblasts were transfected
with 100–200 nM duplex RNAs or 50–100 nM antisense RNA
oligos using the lipofectamine reagent (Invitrogen) in serum-free
Optimem (Gibco-BRL). QMb and QMb-ts myoblasts were
transfected at 35uC for 4 hours, fed with fresh GM and, 24 hours
later, transferred to DM at 41uC for different times. QMb-ts
myotubes, kept at 41uC in DM for at least 24 hours, were
transfected for 4 hours and maintained at 41uC in DM for further
24 hours. C2C12 and L6C5 myoblasts were transfected at 37uCi n
GM and, after 4 hours, medium was replaced with fresh GM and
maintained for a minimum of 24 hours, or shifted to DM for at
least 2 days. MSC were transfected with 50 nM duplex RNAs
using the HiPerfect reagent (Qiagen). Transfection was performed
either when medium was replaced with DM or after 24 hours in
DM. Transfection efficiency of miRNA duplex oligonucleotides
was monitored in each experiment by real time PCR quantifica-
tion and miR-221/222 levels were found to be at least 400-fold
higher than the endogenous miRNA levels.
For the expression of luciferase reporter constructs, 50 ng of
pGL3 (Promega) and pGL3-derived plasmids were co-transfected
with 50 ng of pRL-TK (Promega) per 10
5 cells to normalize for
transfection efficiency using the lipofectamine reagent in serum-
free Optimem. In some experiments, a pGL3 construct containing
the human p27mRNA-39UTR (h-UTR, obtained by A. Fusco,
[24]) was also used. When required, 50–100 nM of duplex or
antisense RNAs were co-transfected with plasmid DNA. QMb-ts
myoblasts were transfected at 35uC, transferred in DM, and then
either kept at 35uC or shifted to 41uC to induce differentiation.
24–48 hours later, cells were lysed and luciferase expression was
measured with the Dual Luciferase Assay kit (Promega) using a
luminometer (Lumat LB9507, Berthold).
Bromo-deoxyuridine labeling and immunofluorescence
analysis
For bromo-deoxyuridine (BrdU) incorporation studies, QMb-ts
transfected at 35uC were shifted to 41uC in DM and labeled with
20 mM BrdU for 2 hours at various times following temperature
shift, as required. Following BrdU incorporation, cells were fixed
and processed for immunofluorescence. Cultures to be analyzed
by immunofluorescence were routinely fixed with 4% parafor-
maldehyde, permeabilized with 0.25% TritonX-100 in Phosphate
Buffered Saline and processed as previously described [39]. For
labeling with rabbit polyclonal antibodies to myosin, following
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cold 100% methanol and washed thoroughly before incubation
with antibodies. For labeling with mAb to myosin heavy chain
(MF20), cultures were fixed with a mixture of 3.5% formaldehyde,
70% ethanol and 5% acidic acid and washed thoroughly before
incubation with antibody. The samples were examined with an
Olympus microscope. Images were recorded on a CCD camera
and processed using a DeltaSystem and Adobe Photoshop
software. Cell scoring was carried out using the public domain
software ImageJ.
Whole-cell extracts and Western blot analysis
Cells were lysed in RIPA buffer (140 mM NaCl, 3 mM MgCl2,
1 mM EDTA, 1 mM orthovanadate, 15 mM Hepes, pH 7.2, also
containing 0.5% Nadeoxycholate, 1% NP-40, 0.1% SDS)
supplemented with a cocktail of protease inhibitors. Western blots
were carried out using horseradish peroxidase-conjugated goat
anti-rabbit and anti-mouse antibodies and revealed with a
chemiluminescence detection system by Pierce. Quantitation of
the bands was carried out by scanning films using the CanoScan
D2400U by Canon and evaluating band intensity using Im-
ageQuant software.
Statistical Analysis
Variables were analyzed by both Student’s t test and one way
ANOVA and a probability value of p #0.05 was deemed statis-
tically significant. Values are expressed as average 6 standard
error (s.e.).
Supporting Information
Table S1 MiRNA Expression Profiling in Quail Myoblasts
Expressing ts-Src Kinase
Found at: doi:10.1371/journal.pone.0007607.s001 (0.23 MB
XLS)
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